参考文献/References:
[1]Fernandes CJ,Morinaga L,Alves JJ,et al.Cancerassociated thrombosis:the when,how and why.Eur Respir Rev,2019,28(151):180119.
[2]Di Nisio M,van Es N,Buller HR.Deep vein thrombosis and pulmonary embolism.Lancet,2016,388(10063):3060-3073.
[3]Heit JA,Silverstein MD,Mohr DN,et al.Risk factors for deep vein thrombosis and pulmonary embolism:a populationbased casecontrol study.Arch Intern Med,2000,160(6):809-815.
[4]Nazareth A,D’Oro A,Liu JC,et al. Risk factors for postoperative venous thromboembolic events in patients undergoing lumbar spine surgery.Global Spine J,2019,9(4):409-416.
[5]Ma J,Du P,Qin J,et al.Incidence and risk factors predicting deep venous thrombosis of lower extremity following spinal fractures.Sci Rep,2021,11(1):2441.
[6]Chopard R,Albertsen IE,Piazza G.Diagnosis and treatment of lower extremity venous thromboembolism:a review.JAMA,2020,324(17):1765-1776.
[7]Senders ZJ,Zussman BM,Maltenfort MG,et al.The incidence of pulmonary embolism (PE) after spinal fusions.Clin Neurol Neurosurg,2012,114(7):897-901.
[8]Khan F,Tritschler T,Kahn SR,et al.Venous thromboembolism.Lancet,2021,398(10294):64-77.
[9]Venclauskas L,Maleckas A,Arcelus JI.European guidelines on perioperative venous thromboembolism prophylaxis:surgery in the obese patient.Eur J Anaesthesiol,2018,35(2):147-153.
[10]Yuan S,Bruzelius M,Xiong Y,et al.Overall and abdominal obesity in relation to venous thromboembolism.J Thromb Haemost,2021,19(2):460-469.
[11]Frischmuth T,Hindberg K,Gabrielsen ME,et al.Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism.Thromb Haemost,2022,122(2):267-276.
[12]Horvei LD,Braekkan SK,Smith EN,et al.Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism:the Tromso study.J Thromb Haemost,2018,16(1):83-89.
[13]Mulder FI,HorvathPuho E,van Es N,et al.Venous thromboembolism in cancer patients:a populationbased cohort study.Blood,2021,137(14):1959-1969.
[14]Girardi L,Wang TF,Ageno W,et al.Updates in the incidence,pathogenesis,and management of cancer and venous thromboembolism.Arterioscler Thromb Vasc Biol,2023,43(6):824-831.
[15]Stark K,Massberg S.Interplay between inflammation and thrombosis in cardiovascular pathology.Nat Rev Cardiol,2021,18(9):666-682.
[16]Henke P.Endothelial cellmediated venous thrombosis.Blood,2022,140(13):1459-1460.
[17]Rawish E,Nording H,Munte T,et al.Platelets as mediators of neuroinflammation and thrombosis.Front Immunol,2020,11:548631.
[18]Bonaca MP,Bauersachs RM,Anand SS,et al.Rivaroxaban in peripheral artery disease after revascularization.N Engl J Med,2020,382(21):1994-2004.
[19]Eikelboom JW,Connolly SJ,Bosch J,et al.Rivaroxaban with or without aspirin in stable cardiovascular disease.N Engl J Med,2017,377(14):1319-1330.
[20]D’Astous J,Liederman Z,Douketis JD.Venous thromboembolism prophylaxis in highrisk orthopedic and cancer surgery.Postgrad Med,2021,133(Sup1):20-26.
[21]田苗,李秀婷,周琪,等.脊柱后路术中深静脉血栓形成的危险因素及物理预防的研究进展.全科护理,2022,20(9):1168-1172.
[22]Sebastian AS,Currier BL,Clarke MJ,et al.Thromboembolic disease after cervical spine surgery: a review of 5,405 surgical procedures and matched cohort analysis.Global Spine J,2016,6：465-471.
[23]Reinisch JF,Bresnick SD,Walker JW,et al.Deep venous thrombosis and pulmonary embolus after face lift:a study of incidence and prophylaxis.Plast Reconstr Surg,2001,107(6):1570-1577.
[24]Finsterwald M,Muster M,Farshad M,et al.Spinal versus general anesthesia for lumbar spine surgery in high risk patients:perioperative hemodynamic stability,complications and costs.J Clin Anesth,2018,46:3-7.
[25]Liu D,Sun C,Zhang X,et al.Influence of epidural anesthesia and general anesthesia on thromboembolism in patients undergoing total knee arthroplasty.Am J Transl Res,2021,13(9):10933-10941.
[26]Turan A,Bajracharya GR,Leung S,et al.Association of neuraxial anesthesia with postoperative venous thromboembolism after noncardiac surgery:a propensitymatched analysis of ACSNSQIP database.Anesth Analg,2019,128(3):494-501.
[27]Ni EA,Singleton BN,Moorthy A,et al.Regional and neuraxial anaesthesia techniques for spinal surgery:a scoping review.Br J Anaesth,2022,129(4):598-611.
[28]Lee JK,Park JH,Hyun SJ,et al.Regional anesthesia for lumbar spine surgery:can it be a standard in the future?Neurospine,2021,18(4):733-740.
[29]Porter J,Crowe B,Cahill M,et al.The effects of ropivacaine hydrochloride on platelet function:an assessment using the platelet function analyser (PFA100).Anaesthesia,2001,56(1):15-18.
[30]Kodali BS,Sa Rego M,Kaynar AM,et al.The effects of 2chloroprocaine on coagulation and fibrinolysis in the parturient: an in vitro study.J Anesth,2014,28(6):906-910.
[31]OliveiraPaula GH,Lacchini R,Pinheiro LC,et al.Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol.Nitric Oxide,2018,75:77-84.
[32]Tan CH,Onsiong MK.Pain on injection of propofol.Anaesthesia,1998,53(5):468-476.
[33]WojewodzkaZelezniakowicz M,Kisiel W,Kramkowski K,et al.Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats.J Renin Angiotensin Aldosterone Syst,2016,17(2):1470320316647239.
[34]Chung BC,Bouz GJ,Mayfield CK,et al.Dosedependent early postoperative opioid use is associated with periprosthetic joint infection and other complications in primary TJA.J Bone Joint Surg Am,2021,103(16):1531-1542.
[35]Cozowicz C,Olson A,Poeran J,et al.Opioid prescription levels and postoperative outcomes in orthopedic surgery.Pain,2017,158(12):2422-2430.
[36]Liu M,Jayaraman K,Giri T,et al.Role of SIRT1 in isoflurane conditioninginduced neurovascular protection against delayed cerebral ischemia secondary to subarachnoid hemorrhage.Int J Mol Sci,2021,22(8):4291.
[37]Jayaraman K,Liu M,Zipfel GJ,et al.Sevoflurane and desflurane exposures following aneurysmal subarachnoid hemorrhage confer multifaceted protection against delayed cerebral ischemia.Biomedicines,2021,9(7):820.
[38]Goel R,Patel EU,Cushing MM,et al.Association of perioperative red blood cell transfusions with venous thromboembolism in a north american registry.JAMA Surg,2018,153(9):826-833.
[39]Gillespie AH,Doctor A.Red blood cell contribution to hemostasis.Front Pediatr,2021,9:629824.
[40]Weisel JW,Litvinov RI.Red blood cells:the forgotten player in hemostasis and thrombosis.J Thromb Haemost,2019,17(2):271-282.
[41]Garraud O,Tariket S,Sut C,et al.Transfusion as an inflammation hit:knowns and unknowns.Front Immunol,2016,7:534.
[42]Stubbs MJ,Mouyis M,Thomas M.Deep vein thrombosis.BMJ,2018,360:k351.
[43]Li L,Huang J,Chen X,et al.A retrospective analysis of the postoperative effect of intraoperative hypothermia on deep vein thrombosis after intracranial tumor resection.World Neurosurg,2022,167:e778-e783.
[44]ElAshmawy NE,Lashin AA,Okasha KM,et al.The plausible mechanisms of tramadol for treatment of COVID19.Med Hypotheses,2021,146:110468.
[45]Iida H,Onuma T,Nakashima D,et al.Tramadol regulates the activation of human platelets via Rac but not Rho/Rhokinase.PLoS One,2023,18(1):e279011.
[46]Kovacic A,Caprnda M,Mrhar A,et al.Impact of drugs on venous thromboembolism risk in surgical patients.Eur J Clin Pharmacol,2019,75(6):751-767.
[47]Stiller CO,Hjemdahl P.Lessons from 20 years with COX2 inhibitors: Importance of doseresponse considerations and fair play in comparative trials.J Intern Med,2022,292(4):557-574.
[48]Ungprasert P,Srivali N,Wijarnpreecha K,et al.Nonsteroidal antiinflammatory drugs and risk of venous thromboembolism:a systematic review and metaanalysis.Rheumatology (Oxford),2015,54(4):736-742.